Spinal Implant and Devices Market by Type (Spinal Fusion Implants, Spinal Bone Stimulators, Vertebral Compression Fracture (VCF) Devices, Motion Preservation Devices, and Spine Biologics) and Surgery (Open Spine Surgery and Minimally Invasive Spine Surgery): Global Opportunity Analysis and Industry Forecast 2020–2027
- ALL4001240
- 268 Pages
- July 2020
- Pharmaceuticals
Spine-related disorders and deformities are treated using spinal implants and devices. Disorders such as spinal stenosis and lumbar degenerative spondylolisthesis are caused from degeneration of intervertebral disc, deformity, tumors, and trauma. In addition, implant systems utilize specially designed spinal instrumentation such as plates, rods, and screws, which help to facilitate fusion, correct deformities, and stabilize and strengthen the spine. Most spinal implants are made of metals such as titanium and are available in different shapes and sizes to be used in patients of all ages.
The market is driven by shift toward minimally invasive spine procedure. Growth in elderly population and rise in incidences of spinal disorders attributed to sedentary lifestyle is expected to drive the market growth. In addition, advancements in spine surgeries and new product launches further fuel the market. However, stringent regulatory approval procedures, present pandemic situation and unfavorable reimbursement scenario are expected to hamper growth of the spinal implant and devices market. Moreover, emerging markets are expected to drive demand for spinal implants and devices and advancements in augmented and virtual reality, endoscopic surgery and 3D printed implants for minimally invasive surgery are also expected to fuel the market growth.
The report segments the spinal implants and devices market on the basis of type, surgery, and region. According to the product type, it is segmented into spinal fusion implants, motion preservation devices, vertebral compression fracture (VCF) devices, spine bone stimulators and spine biologics. By surgery type, it is bifurcated into open spine surgery and minimally invasive spine surgery. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Over the past few years, key players have adopted product development such as product launches, approvals, and clinical trials as their key strategies. For instance, in September 2019, J&J launched a 3D Printed Implant Portfolio (CONDUIT Interbody Platform with EIT Cellular Titanium Technology) for spine surgery to expand comprehensive offering to treat degenerative spine disease. Moreover, in February 2019, Orthofix received US Food and Drug Administration (FDA) approval for M6-C artificial cervical disc (Orthofix Medical) for patients suffering from cervical disc degeneration. This artificial disc was developed by Spinal Kinetics.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global spinal implants and devices market with current trends and future estimations from 2019 to 2027 to elucidate the imminent investment pockets.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
• Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Key Market Segments
By Type
• Spinal Fusion Implants
o Thoracolumbar Devices
Anterior Lumbar Plates
Lumbar Plates
Pedicle Screw
Rods
Hooks
Wires & Cables
Crosslinks
o Cervical Fixation Devices
Anterior Cervical Plates
Hook Fixation Systems
Plates & Screws
Clamps
Wires
o Interbody Fusion Devices
Non-Bone Interbody Fusion Devices
Bone Interbody Fusion Devices
• Vertebral Compression Fracture (VCF) Devices
o Balloon Kyphoplasty Devices
o Vertebroplasty Devices
• Motion Preservation Devices
o Dynamic Stabilization Devices
Interspinous Process Spacers
Pedicle Screw-Based Systems
Facet Replacement Products
o Artificial Discs
Artificial Cervical Discs
Artificial Lumbar Discs
o Annulus Repair Devices
o Nuclear Disc Prostheses
• Spine bone stimulators
o Non-Invasive Spine Bone Stimulators
Pulsed Electromagnetic Field Device
Capacitive Coupling (CC) and Combined (Electro) Magnetic Field (CMF) Devices
o Invasive Spine Bone Stimulators
• Spine Biologics
o Spinal Allografts
Machined Bones Allograft
Demineralized Bone Matrix
o Bone Graft Substitutes
Bone Morphogenetic Proteins
Synthetic Bone Grafts
o Cell-Based Matrix
By Surgery
• Open Spine Surgery
• Minimally Invasive Spine Surgery
By Region
o North America
U.S.
Canada
Mexico
o Europe
UK
Germany
France
Italy
Spain
Rest of Europe
o Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
o LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA
List of key players profiled in the report
• Alphatec Holdings, Inc.
• B. Braun Melsungen AG
• Exactech, Inc.
• Johnson & Johnson (DePuy Synthes)
• Globus Medical, Inc.
• Medtronic plc
• Nuvasive, Inc.
• Orthofix International N.V.
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
List of the other key players (not included in the report) includes Aesculap Implant Systems, Aspen Medical Products, Amedica Corp., Camber Spine Technologies, Paragon Medical, Inc., Norman Noble, Inc., Nutech, Titan Spine, Wenzel Spine, Inc., X-spine Systems, Inc., Tecomet, Inc., Marox Corporation, Axial Medical, Spine Wave, Inc., K2M, Inc., and Captiva Spine, LLC.
1.1.KEY BENEFITS
1.2.KEY MARKET SEGMENTS
1.3.Key players
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top winning strategies
3.2.2.Top investment pockets
3.3.Top player positioning, 2019
3.4.Market share analysis, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Growing elderly population
3.5.1.2.Increasing prevalence of spinal disorders due to sedentary lifestyles
3.5.1.3.Advancements in spine surgery
3.5.1.4.Increase in demand for minimally invasive surgical procedures
3.5.2.Restraints
3.5.2.1.Stringent regulatory approval procedure
3.5.2.2.Unfavorable reimbursement scenario
3.5.3.Opportunities
3.5.3.1.Emerging markets to drive the demand for spinal implants and devices
3.5.3.2.Advancement in augmented & virtual reality, endoscopic surgery and 3D printed implants for minimally invasive spine surgery
3.5.4.Impact analysis
3.6.Porter’s five forces analysis
3.6.1.Bargaining power of buyers
3.6.2.Bargaining power of suppliers
3.6.3.Threat of substitutes
3.6.4.Threat of new entrants
3.6.5.Competitive rivalry
3.7.Clinical trials
3.8.Government regulations
3.9.Impact analysis of the Covid -19 for spinal implant and devices market
CHAPTER 4:SPINAL IMPLANTS AND DEVICES MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Spinal Fusion Devices
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market share analysis, by country
4.2.4.Thoracolumbar devices
4.2.4.1.Market size and forecast
4.2.5.Cervical Fixation Devices
4.2.5.1.Market size and forecast
4.2.6.Interbody Fusion Devices
4.2.6.1.Market size and forecast
4.3.Spine Bone Stimulators
4.3.1.Key market trends and opportunity
4.3.2.Market size and forecast
4.3.3.Market share analysis, by country
4.3.4.Non-invasive spine bone stimulators
4.3.4.1.Market size and forecast
4.3.5.Invasive spine bone stimulators
4.3.5.1.Market size and forecast
4.4.Motion Preservation Devices
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast
4.4.3.Market share analysis, by country
4.4.4.Dynamic stabilization systems
4.4.4.1.Market size and forecast
4.4.5.Artificial Discs
4.4.5.1.Market size and forecast
4.4.6.Annulus repair devices
4.4.6.1.Market size and forecast
4.4.7.Nucleus disc prosthesis device
4.4.7.1.Market size and forecast
4.5.Vertebral Compression Fracture Devices
4.5.1.Key market trends and opportunity
4.5.2.Market size and forecast
4.5.3.Market share analysis, by country
4.5.4.Balloon kyphoplasty devices
4.5.4.1.Market size and forecast
4.5.5.Vertebroplasty devices
4.5.5.1.Market size and forecast
4.6.Spine Biologics
4.6.1.Key market trends and opportunities
4.6.2.Market size and forecast
4.6.3.Market share analysis, by country
4.6.4.Spinal allografts
4.6.4.1.Market size and forecast
4.6.5.Bone graft substitutes
4.6.5.1.Market size and forecast
4.6.6.Cell based matrix
4.6.6.1.Market size and forecast
CHAPTER 5:SPINAL IMPLANTS AND DEVICES MARKET, BY SURGERY
5.1.Overview
5.1.1.Market size and forecast
5.2.Open Spine Surgery
5.2.1.Market size and forecast
5.2.2.Market share analysis, by country
5.3.Minimally Invasive Spine Surgery
5.3.1.Market size and forecast
5.3.2.Market share analysis, by country
CHAPTER 6:SPINAL IMPLANTS AND DEVICES MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.North America market size and forecast, by country
6.2.3.North America market size and forecast, by Type
6.2.4.North America market size and forecast, by Surgery
6.2.4.1.U.S.
6.2.4.1.1.U.S. market size and forecast, by Type
6.2.4.1.2.U.S. market size and forecast, by Surgery
6.2.4.2.Canada
6.2.4.2.1.Canada market size and forecast, by Type
6.2.4.2.2.Canada market size and forecast, by Surgery
6.2.4.3.Mexico
6.2.4.3.1.Mexico market size and forecast, by Type
6.2.4.3.2.Mexico market size and forecast, by Surgery
6.3.Europe
6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast
6.3.3.Europe market size and forecast, by Type
6.3.4.Europe market size and forecast, by Surgery
6.3.4.1.Germany
6.3.4.1.1.Germany market size and forecast, by Type
6.3.4.1.2.Germany market size and forecast, by Surgery
6.3.4.2.UK
6.3.4.2.1.UK market size and forecast, by Type
6.3.4.2.2.UK market size and forecast, by Surgery
6.3.4.3.France
6.3.4.3.1.France market size and forecast, by Type
6.3.4.3.2.France market size and forecast, by Surgery
6.3.4.4.Italy
6.3.4.4.1.Italy market size and forecast, by Type
6.3.4.4.2.Italy market size and forecast, by Surgery
6.3.4.5.Spain
6.3.4.5.1.Spain market size and forecast, by Type
6.3.4.5.2.Spain market size and forecast, by Surgery
6.3.4.6.Rest of Europe
6.3.4.6.1.Rest of Europe market size and forecast, by Type
6.3.4.6.2.Rest of Europe market size and forecast, by Surgery
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Market size and forecast
6.4.3.Asia-Pacific market size and forecast, by Type
6.4.4.Asia-Pacific market size and forecast, by Surgery
6.4.4.1.India
6.4.4.1.1.India market size and forecast, by Type
6.4.4.1.2.India market size and forecast, by Surgery
6.4.4.2.China
6.4.4.2.1.China market size and forecast, by Type
6.4.4.2.2.China market size and forecast, by Surgery
6.4.4.3.Japan
6.4.4.3.1.Japan market size and forecast, by Type
6.4.4.3.2.Japan market size and forecast, by Surgery
6.4.4.4.Australia
6.4.4.4.1.Australia market size and forecast, by Type
6.4.4.4.2.Australia market size and forecast, by Surgery
6.4.4.5.South Korea
6.4.4.5.1.South Korea market size and forecast, by Type
6.4.4.5.2.South Korea market size and forecast, by Surgery
6.4.4.6.Rest of Asia-Pacific
6.4.4.6.1.Rest of Asia-Pacific market size and forecast, by Type
6.4.4.6.2.Rest of Asia-Pacific market size and forecast, by Surgery
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.Market size and forecast
6.5.3.LAMEA market size and forecast, by Type
6.5.4.LAMEA market size and forecast, by Surgery
6.5.4.1.Brazil
6.5.4.1.1.Brazil market size and forecast, by Type
6.5.4.1.2.Brazil market size and forecast, by Surgery
6.5.4.2.Saudi Arabia
6.5.4.2.1.Saudi Arabia market size and forecast, by Type
6.5.4.2.2.Saudi Arabia market size and forecast, by Surgery
6.5.4.3.South Africa
6.5.4.3.1.South Africa market size and forecast, by Type
6.5.4.3.2.South Africa market size and forecast, by Surgery
6.5.4.4.Rest of LAMEA
6.5.4.4.1.Rest of LAMEA market size and forecast, by Type
6.5.4.4.2.Rest of LAMEA market size and forecast, by Surgery
CHAPTER 7:COMPANY PROFILES
7.1.Alphatec Holdings, Inc.
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating Business Segment
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.B. Braun Melsungen AG
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.3.Exactech, Inc.
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating Business Segments
7.3.4.Product portfolio
7.4.Johnson & Johnson (DePuy Synthes)
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.Globus Medical, Inc.
7.5.1.Company overview
7.5.2.Company snapshot
7.5.1.Operating Business Segments
7.5.2.Product portfolio
7.5.3.Business performance
7.6.Medtronic plc.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.6.6.Key strategic moves and developments
7.7.Nuvasive, Inc.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.7.6.Key strategic moves and developments
7.8.Orthofix International N.V.
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating Business Segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments
7.9.Stryker Corporation
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.Zimmer Biomet Holdings, Inc.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating Product Categories
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments
TABLE 01.CLINICAL TRIALS: SPINAL IMPLANT AND DEVICES MARKET, 2010-2020
TABLE 02.GLOBAL SPINAL IMPLANTS AND DEVICES MARKET, BY TYPE ($MILLION), 2019–2027
TABLE 03.GLOBAL SPINAL FUSION DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 04.GLOBAL SPINAL FUSION DEVICES MARKET, BY REGION ($MILLION), 2019-2027
TABLE 05.GLOBAL THORACOLUMBAR FUSION DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 06.GLOBAL CERVICAL FIXATION DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 07.GLOBAL INTERBODY FUSION DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 08.GLOBAL SPINE BONE STIMULATORS MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 09.GLOBAL SPINE BONE STIMULATORS MARKET, BY REGION ($MILLION), 2019-2027
TABLE 10.GLOBAL NON-INVASIVE SPINE BONE STIMULATORS MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 11.GLOBAL MOTION PRESERVATION DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 12.GLOBAL MOTION PRESERVATION DEVICES MARKET, BY REGION ($MILLION), 2019-2027
TABLE 13.GLOBAL DYNAMIC STABILIZATION DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 14.GLOBAL ARTIFICIAL DISCS MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 15.GLOBAL VCF DEVICES MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 16.GLOBAL VCF DEVICES MARKET, BY REGION ($MILLION), 2019-2027
TABLE 17.GLOBAL SPINE BIOLOGICS MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 18.GLOBAL SPINE BIOLOGICS MARKET, BY REGION ($MILLION), 2019-2027
TABLE 19.GLOBAL SPINAL ALLOGRAFT MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 20.GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE ($MILLION), 2019 - 2027
TABLE 21.GLOBAL SPINAL IMPLANTS AND DEVICES MARKET, BY SURGERY TYPE ($MILLION), 2019-2027
TABLE 22.GLOBAL OPEN SPINE SURGERY MARKET, BY REGION ($MILLION), 2019-2027
TABLE 23.GLOBAL MINIMALLY INVASIVE SPINE SURGERY MARKET, BY REGION ($MILLION), 2019-2027
TABLE 24.GLOBAL SPINAL IMPLANTS AND DEVICES MARKET, BY REGION ($MILLION), 2019-2027
TABLE 25.NORTH AMERICA SPINAL IMPLANT AND DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 26.NORTH AMERICA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 27.NORTH AMERICA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 28.U.S. SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 29.U.S. SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 30.CANADA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 31.CANADA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 32.MEXICO SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 33.MEXICO SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 34.EUROPE SPINAL IMPLANTS AND DEVICES MARKET, BY COUNTRY, ($MILLION) 2019-2027
TABLE 35.EUROPE SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 36.EUROPE SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 37.GERMANY SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 38.GERMANY SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 39.UK SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 40.UK SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 41.FRANCE SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 42.FRANCE SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 43.ITALY SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 44.ITALY SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 45.SPAIN SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 46.SPAIN SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 47.REST OF EUROPE SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 48.REST OF EUROPE SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 49.ASIA-PACIFIC SPINAL IMPLANTS AND DEVICES MARKET, BY COUNTRY ($MILLION), 2019-2027
TABLE 50.ASIA-PACIFIC SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 51.ASIA-PACIFIC SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 52.INDIA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 53.INDIA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 54.CHINA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 55.CHINA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 56.JAPAN SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 57.JAPAN SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 58.AUSTRALIA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 59.AUSTRALIA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 60.SOUTH KOREA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 61.SOUTH KOREA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 62.REST OF ASIA- PACIFIC SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 63.REST OF ASIA-PACIFIC SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 64.LAMEA SPINAL IMPLANTS AND DEVICES MARKET, BY COUNTRY ($MILLION), 2019-2027
TABLE 65.LAMEA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 66.LAMEA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 67.BRAZIL SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 68.BRAZIL SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 69.SAUDI ARABIA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 70.SAUDI ARABIA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 71.SOUTH AFRICA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 72.SOUTH AFRICA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 73.REST OF LAMEA SPINAL IMPLANT AND DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 74.REST OF LAMEA SPINAL IMPLANT AND DEVICES MARKET, BY SURGERY, 2019–2027 ($MILLION)
TABLE 75.ALPHATEC: COMPANY SNAPSHOT
TABLE 76.ALPHATEC: OPERATING SEGMENT:
TABLE 77.ALPHATEC: PRODUCT PORTFOLIO
TABLE 78.B. BRAUN: COMPANY SNAPSHOT
TABLE 79.B. BRAUN: BUSINESS SEGMENTS
TABLE 80.B. BRAUN: PRODUCT PORTFOLIO
TABLE 81.EXACTECH: COMPANY SNAPSHOT
TABLE 82.EXACTECH: BUSINESS SEGMENTS
TABLE 83.EXACTECH: PRODUCT PORTFOLIO
TABLE 84.J&J: COMPANY SNAPSHOT
TABLE 85.J&J: BUSINESS SEGMENTS
TABLE 86.J&J: PRODUCT PORTFOLIO
TABLE 87.GLOBUS MEDICAL: COMPANY SNAPSHOT
TABLE 88.GLOBUS MEDICAL.: OPERATING SEGMENTS
TABLE 89.GLOBUS MEDICAL: PRODUCT PORTFOLIO
TABLE 90.MEDTRONIC: COMPANY SNAPSHOT
TABLE 91.MEDTRONIC: BUSINESS SEGMENTS
TABLE 92.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 93.NUVASIVE: COMPANY SNAPSHOT
TABLE 94.NUVASIVE: BUSINESS SEGMENTS
TABLE 95.NUVASIVE: PRODUCT PORTFOLIO
TABLE 96.ORTHOFIX: COMPANY SNAPSHOT
TABLE 97.ORTHOFIX: BUSINESS SEGMENTS
TABLE 98.ORTHOFIX: PRODUCT PORTFOLIO
TABLE 99.STRYKER: COMPANY SNAPSHOT
TABLE 100.STRYKER: BUSINESS SEGMENTS
TABLE 101.STRYKER: PRODUCT PORTFOLIO
TABLE 102.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 103.ZIMMER BIOMET: BUSINESS SEGMENTS
TABLE 104.ZIMMER BIOMET: PRODUCT PORTFOLIO
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
